This HTML5 document contains 61 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1093/ANNONC/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57820342
rdf:type
wikibase:Item
schema:description
scientific article published on 19 December 2005 наукова стаття, опублікована в грудні 2005 wetenschappelijk artikel article scientifique publié en 2005 artículu científicu espublizáu n'avientu de 2005 im Dezember 2005 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q57820342-EAA0AC28-5AF7-4C22-B8A6-1AAD27528F1C
wdt:P577
2005-12-19T00:00:00Z
p:P2093
wds:Q57820342-F92A9301-9BAA-4E24-BEAD-B2ABEFF25541 wds:Q57820342-2946C7A7-12FB-4BBD-94C1-AA96453BA4AC wds:Q57820342-54EA757E-EEBC-4EAD-BE24-877621B85D10 wds:Q57820342-2F4AD4C7-D450-43A0-917A-E6A304B3EA53 wds:Q57820342-68E48863-60DB-4EBD-BA11-8D05676D5546 wds:Q57820342-59948127-4327-4BD1-9DF4-91E58B7353C9 wds:Q57820342-5F35F834-52A2-4A30-98A1-A049B21F9EFD wds:Q57820342-9CB8C6A3-A53C-42BC-80B8-4E0C16538AF9 wds:Q57820342-CC7AA7B5-C51F-45BB-8A5E-4728692C29B3 wds:Q57820342-CC4CF80D-B762-4668-9DFA-9C34A69E558B
wdt:P2093
V Ziparo V David C Bordi P Pederzoli E Iannicelli C L Maini M S Cattaruzza G Delle Fave R Sciuto M Di Fonzo
rdfs:label
Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma
skos:prefLabel
Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma
schema:name
Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma
p:P50
wds:Q57820342-3D21EE71-8D8A-405F-8E4C-BC676FC73FB2 wds:Q57820342-05D3A6F8-7DDC-45ED-A371-C6E5D0864414 wds:Q57820342-CF0EB3E4-59A6-4157-9510-50748EFAA523 wds:Q57820342-8988751F-B1BC-4ACC-9870-FD2601102A1D
wdt:P50
wd:Q59544981 wd:Q37378032 wd:Q43290010 wd:Q37842010
p:P1476
wds:Q57820342-72A96742-251E-43B3-93EB-B1806E55418D
wdt:P1476
Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma
p:P304
wds:Q57820342-839227E1-5466-4ACE-B87A-37BFFF4B04F9
wdt:P304
461-466
p:P31
wds:Q57820342-16916CCF-FF6D-4C12-A7E1-DCDF9F24F785
wdt:P31
wd:Q13442814
p:P698
wds:Q57820342-A54034B6-FBEA-4281-9555-6FE69FC98248
wdtn:P698
n11:16364959
wdt:P698
16364959
p:P1433
wds:Q57820342-BB88AEF7-46AD-445F-A0E2-97DBD6E8C7D9
wdt:P1433
wd:Q326122
p:P433
wds:Q57820342-27F4E34D-D444-4424-8D27-879F2E072435
p:P478
wds:Q57820342-449245E4-C0D5-4CCD-8A5D-1428C0F9F24E
wdt:P433
3
wdt:P478
17
p:P356
wds:Q57820342-14AD534F-B00C-4C48-88CD-E6C11323CDC2
wdtn:P356
n10:MDJ113
wdt:P356
10.1093/ANNONC/MDJ113